Roth Lab Featured on Cover of Cell
Bryan Roth, PhD, and his lab report the first crystal structure of LSD bound to one of its molecular targets, the serotonin 5-HT2B receptor.
Bryan Roth, PhD, and his lab report the first crystal structure of LSD bound to one of its molecular targets, the serotonin 5-HT2B receptor.
The UNC School of Medicine has awarded the 17th Perl-UNC Neuroscience Prize to David Anderson, PhD, the Seymour BenzerDavid Anderson, PhD Professor of Biology at the California Institute of Technology for “his discovery of neural circuit mechanisms controlling emotional behaviors.”
Smith Lab publishes in Nature Neuroscience, “Stream-dependent development of higher visual cortical areas”.
Dr. Gabriel Dichter, a Carolina Institute for Developmental Disabilities (CIDD) Investigator, was recently awarded a grant from the National Institute of Mental Health to evaluate dopaminergic functioning during reward processing in individuals with autism spectrum disorder.
On Saturday December 10, 2016, Harvey’s Aces Celebrity Poker Tournament will be held at the Charlotte Museum of History. Proceeds will be donated to the Angelman Syndrome Foundation Clinic at Chapel Hill and the Harvey Baseball Foundation, two non-profit organizations that former professional baseball player Bryan Harvey helped create.
An article from Tim Gershon’s lab is featured on the cover of this month’s issue of Development.
Collaboration between the UNC School of Medicine and the University of Minnesota aims to provide scientists with breakthrough information about how the human brain develops from birth through early childhood.
The Pitt Hopkins Research foundation awarded its first ever gene therapy grant to Drs. Ben Philpot & Steve Gray, who are are collaborating on a project to investigate the feasibility of a gene therapy approach for Pitt-Hopkins syndrome (PTHS).
Spencer Smith has published two reviews in the September, 2016 issue of Nature Neuroscience
UNC School of Medicine researchers map the anxiety circuit in the brain and use a compound to limit fearful behavior – an acute side effect of commonly prescribed SSRI antidepressants.